These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9807197)
21. The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible? Mueck AO; Seeger H Gynecol Endocrinol; 2008 Mar; 24(3):129-32. PubMed ID: 18335326 [TBL] [Abstract][Full Text] [Related]
22. [Clinical use of progestins]. Brizzi C; Serrao L; Primiero FM Clin Ter; 1994 Oct; 145(10):325-30. PubMed ID: 7820990 [TBL] [Abstract][Full Text] [Related]
23. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
24. Hormone therapy and breast cancer risk. Foidart JM; Desreux J; Pintiaux A; Gompel A Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674 [TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study. Nozaki M; Koera K; Nagata H; Nakano H J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106 [TBL] [Abstract][Full Text] [Related]
26. [Menopause and hormone replacement therapy]. Tóth KS Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167 [TBL] [Abstract][Full Text] [Related]
27. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France]. Jamin C; Bourg F; Legeai J; Senoussi S Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401 [TBL] [Abstract][Full Text] [Related]
28. Breast cancer risk with postmenopausal hormonal treatment. Collins JA; Blake JM; Crosignani PG Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813 [TBL] [Abstract][Full Text] [Related]
29. Impact of metabolism on the safety of estrogen therapy. Prokai-Tatrai K; Prokai L Ann N Y Acad Sci; 2005 Jun; 1052():243-57. PubMed ID: 16024767 [TBL] [Abstract][Full Text] [Related]
33. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated]. Emons G; Westphalen S MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648 [TBL] [Abstract][Full Text] [Related]
35. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy. Twombly R J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368 [No Abstract] [Full Text] [Related]
36. The rationale for a wider range of progestogens. Skouby SO Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382 [TBL] [Abstract][Full Text] [Related]
37. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS; J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331 [TBL] [Abstract][Full Text] [Related]
38. Estrogen use and endometrial cancer. Sturgis SH N Engl J Med; 1979 Apr; 300(16):922. PubMed ID: 423942 [No Abstract] [Full Text] [Related]
39. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study. Vassilopoulou-Sellin R; Cohen DS; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Smith TL; Theriault RL Cancer; 2002 Nov; 95(9):1817-26. PubMed ID: 12404273 [TBL] [Abstract][Full Text] [Related]
40. [Endocrine system. a. Hormone replacement therapy--improvement of in bone metabolism and cancer risk of long term therapy]. Ota H Nihon Sanka Fujinka Gakkai Zasshi; 1994 Aug; 46(8):749-63. PubMed ID: 8089612 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]